| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Managing Media Replication Projects |
|
Digg It - Managing Media Replication Projects
The goals of every media replication and packaging project are:
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product project's business goals. The first step to achieving these goals is to establish a budget and timeline tha ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in meets all project requirements. The best way to ensure that timing and budgetary restraints are met is to involve all the pertinent players from the start. On many projects, the repl lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ication and packaging people are brought in too late to optimize the campaign's effectiveness. Too often decisions are made without the input of key participants in the process, result here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ng in a truncated replication and packaging timeline and less- than- optimal product costing more than it should. The participation of replication and packaging experts throug d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro out the process more effectively organizes your project. They can be particularly helpful in identifying opportunities for improving efficiency. In many cases, for example, key media pa ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ckaging elements and the final media content development stages can be produced concurrently. Most importantly the early involvement of a seasoned media replication and packaging profe easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi sional can give the project more options and help avoid challenging situations before they occur. Organizing a Media Replication and Packaging Project There are steps to be tak nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n and questions to be asked at the offset of all media replication projects. Working through each step ensures the most efficient process and highest quality results.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ lish business goals - what are you trying to accomplish?
< ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi l>
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a w many people does the campaign need to reach? dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod d to get final product to the end-user.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin DVD, or VHS.
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ct? Can it fit on a CD? t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ortance to the final product's design element.
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust view the media? y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nd impact goals of the project.
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de any's product is packaged with the final unit?
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip > Is a Business Reply Card needed? tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Start Your Information Technology Career - Or Jumpstart It! Looking for Word-of-Mouth Referrals
|